AEON Biopharma, Inc. (AEON) stock
Close on Nov 13, 2026Market cap $7.63MP/E –Yield –
AEON Biopharma statistics
52 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Nov 13, 2026 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Share statisticsIndustry
- Shares Change (YoY)
- 613.8%
- 10.8%
- Shares Change (QoQ)
- 3.97%
- 0.50%
- Shares Held by Institutions
- 25.7%
- 56.4%
Short sellingIndustry
- Short Interest
- 3M
- –
- Short Interest Change
- -18.1%
- -0.80%
- Short % of Shares Outstanding
- 5.34%
- 6.30%
- Days to Cover
- 6.40
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $1.45
- –
- 52-Week Low
- $0.13
- –
- 20-Day Moving Average
- $0.22
- –
- 50-Day Moving Average
- $0.25
- –
- 200-Day Moving Average
- $0.63
- –
- Average True Range (14)
- $0.03
- –
- Price Change (1 Week)
- -13.0%
- -1.15%
- Price Change (1 Month)
- -37.0%
- -4.87%
- Price Change (3 Months)
- -40.1%
- -21.0%
- Price Change (6 Months)
- -78.8%
- -20.6%
- Price Change (YTD)
- -86.1%
- -23.6%
- Price Change (1 Year)
- -83.2%
- -22.4%
- Price Change (3 Years)
- -100.0%
- -29.5%
- Price Change (5 Years)
- -100.0%
- -77.9%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 893,397
- –
- Average Volume (90 Days)
- 6M
- –
- Relative Volume
- 0.12
- 0.70
- Relative Strength Index (14)
- 32.2
- 43.4
- Volatility (1 Year)
- 109.9%
- 80.1%
- Beta (5 Years)
- 0.72
- 1.07
Returns on capitalIndustry
- Return on Assets (ROA)
- -621.7%
- -40.6%
Financial positionIndustry
- Current Ratio
- 0.54
- 3.30
- Quick Ratio
- 0.47
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$6.83M
- -$689.41K
- Employee Count
- 8
- 74
- WACC
- 8.71%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$54.62M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $3.43M
- $17.76M
- Net Cash Per Share
- $0.07
- $0.80
- Equity (Book Value)
- -$15.36M
- $53.89M
- Book Value Per Share
- -$0.31
- $1.50
- Tangible Book Value
- -$15.36M
- $27.13M
- Working Capital
- -$3.35M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -715.7%
- -21.8%
Scores and fair valueIndustry
- Altman Z-Score
- -126.15
- 0.23
- Piotroski F-Score
- 3
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | AEON | S&P 500 | Difference | AEON per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -33.4% | -3.0% | −30.4 pts | ||
| 3 months | -43.5% | -2.8% | −40.7 pts | ||
| Year to date | -86.1% | +11.5% | −97.6 pts | ||
| 1 year | -83.7% | +13.5% | −97.2 pts | ||
| 3 years | -99.9% | +77.7% | −177.6 pts | -92.0% | +21.1% |
| 5 years | -100.0% | +72.6% | −172.6 pts | -81.5% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
3M AEON shares were sold short on Oct 30, 2026, down 18.1% from the previous report. At recent volumes it would take 6.4 days to buy them back. Over the last 20 sessions, 48.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 2,661,529 | -18.1% | 415,775 | 6.4 |
| Oct 15, 2026 | 3,250,700 | +49.7% | 2,133,944 | 1.5 |
| Sep 30, 2026 | 2,171,628 | -26.3% | 11,385,809 | 1.0 |
| Sep 15, 2026 | 2,947,951 | +62.8% | 24,523,114 | 1.0 |
| Aug 31, 2026 | 1,811,171 | +60.8% | 7,389,741 | 1.0 |
| Aug 14, 2026 | 1,126,698 | +28.5% | 343,615 | 3.3 |
| Jul 31, 2026 | 876,967 | -21.2% | 993,401 | 1.0 |
| Jul 15, 2026 | 1,112,789 | +594.3% | 6,550,697 | 1.0 |
| Jun 30, 2026 | 160,269 | -9.9% | 28,986 | 5.5 |
| Jun 15, 2026 | 177,895 | -18.9% | 32,980 | 5.4 |
| May 29, 2026 | 219,220 | -5.5% | 72,592 | 3.0 |
| May 15, 2026 | 231,888 | +48.3% | 69,649 | 3.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?